02389oam 2200565 a 450 991078087930332120231122214614.01-282-76040-89786612760402981-283-298-X(CKB)2490000000001889(EBL)731107(OCoLC)670430493(SSID)ssj0000423692(PQKBManifestationID)11306898(PQKBTitleCode)TC0000423692(PQKBWorkID)10468254(PQKB)10876024(MiAaPQ)EBC731107(WSP)00006943(Au-PeEL)EBL731107(CaPaEBR)ebr10422476(CaONFJC)MIL276040(EXLCZ)99249000000000188920100312d2010 uy 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierMyopia animal models to clinical trials /editors, Roger W. Beuerman [et al.]New Jersey World Scientificc20101 online resource (xxvii, 390 pages) illustrations (some color)981-283-297-1 Includes bibliographical references and index.Epidemiology and risk factors -- Clinical studies and pathologic myopia -- Genetics of myopia -- Animal models and the biological basis of myopia -- Interventions for myopia.Myopia is the most common optical disorder in the world, and is on the rise in many countries, particularly in East Asia. The impact of myopia is evident as the driving force in the development of refractive surgery and of the spectacle and contact lens industries. While myopia is often seen as a childhood disease that involves complex genetic-environmental factors, it is also a major cause of adult blindness. In Singapore (where myopia has reached one of the highest rates in the world) as well as in Taiwan, Japan and Hong Kong, affected patients have greater severity of myopia, leading to addMyopiaDiseasesAnimal modelsMyopia.DiseasesAnimal models.617.7/55Beuerman Roger W.1942-1573720MiAaPQMiAaPQMiAaPQBOOK9910780879303321Myopia3849594UNINA